us fda approval achieved $$$$$$$$$$, page-9

Hi Freakme. thanks for the comments.

I'll be watching closely, and yes I agree, they really should be more around the mid 20's so at the moment they still seem cheap.

Will be waiting for any weakness as, like I said earlier, those that bought around the 15/16 mark and may be exiting for xmas shopping would probably still be happy with sub-20 figures (still a decent return/ profit).

Reckon anything under 20 (ipo price) is a steal now.

Just think of what a small deal in the US could be worth to them and the sp, considering their mkt cap of $6m...